Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-07 1:51 pm Sale | 2024-12-31 | 13G | ADMA Biologics, Inc. ADMA | Invesco Ltd. IVZ | 11,296,255 4.800% | -1,323,514 (-10.49%) | Filing History |
| 2024-11-12 1:34 pm Unchanged | 2024-09-30 | 13G | ADMA Biologics, Inc. ADMA | VANGUARD GROUP INC | 18,118,494 7.770% | 0 (Unchanged) | Filing History |
| 2024-11-08 09:21 am Purchase | 2024-11-08 | 13G | ADMA Biologics, Inc. ADMA | Invesco Ltd. IVZ | 12,619,769 5.500% | 12,619,769 (New Position) | Filing History |
| 2024-11-04 11:00 am Purchase | 2024-09-30 | 13G | ADMA Biologics, Inc. ADMA | VANGUARD GROUP INC | 18,118,494 7.770% | 5,226,619 (+40.54%) | Filing History |
| 2024-10-17 09:22 am Purchase | 2024-09-30 | 13G | ADMA Biologics, Inc. ADMA | STATE STREET CORP STT | 13,004,993 5.600% | 13,004,993 (New Position) | Filing History |
| 2024-10-07 4:08 pm Purchase | 2024-09-30 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 38,269,434 16.400% | 20,351,689 (+113.58%) | Filing History |
| 2024-09-23 4:27 pm Sale | 2024-09-19 | 13G | ADMA Biologics, Inc. ADMA | Millennium Management LLC | 1,374,038 0.600% | -4,880,371 (-78.03%) | Filing History |
| 2024-03-11 12:31 pm Sale | 2024-02-29 | 13G | ADMA Biologics, Inc. ADMA | Teachers Advisors, LLC | 4,955,411 2.170% | -107,134 (-2.12%) | Filing History |
| 2024-03-11 12:24 pm Sale | 2024-02-29 | 13G | ADMA Biologics, Inc. ADMA | TIAA-CREF Investment Management, LLC | 4,955,411 2.170% | -107,134 (-2.12%) | Filing History |
| 2024-03-11 12:19 pm Sale | 2024-02-29 | 13G | ADMA Biologics, Inc. ADMA | Nuveen Asset Management LLC | 4,955,411 2.170% | -107,134 (-2.12%) | Filing History |
| 2024-02-14 4:49 pm Sale | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 6,433,369 2.800% | -5,466,886 (-45.94%) | Filing History |
| 2024-02-14 11:50 am Sale | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | Nuveen Asset Management LLC | 5,062,545 2.240% | -420,824 (-7.67%) | Filing History |
| 2024-02-14 11:47 am Sale | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | Teachers Advisors, LLC | 5,062,545 2.240% | -420,824 (-7.67%) | Filing History |
| 2024-02-14 11:37 am Sale | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | TIAA-CREF Investment Management, LLC | 5,062,545 2.240% | -420,824 (-7.67%) | Filing History |
| 2024-02-13 4:56 pm Purchase | 2023-12-29 | 13G | ADMA Biologics, Inc. ADMA | VANGUARD GROUP INC | 12,891,875 5.710% | 12,891,875 (New Position) | Filing History |
| 2024-01-26 11:49 am Purchase | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | BlackRock Inc. BLK | 17,917,745 7.900% | 2,816,464 (+18.65%) | Filing History |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 11,900,255 5.400% | -33,132 (-0.28%) | Filing History |
| 2023-02-14 08:50 am Purchase | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Nuveen Asset Management LLC | 5,483,369 2.480% | 5,483,369 (New Position) | Filing History |
| 2023-02-14 08:48 am Purchase | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Teachers Advisors, LLC | 5,483,369 2.480% | 5,483,369 (New Position) | Filing History |
| 2023-02-14 08:47 am Purchase | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | TIAA-CREF Investment Management, LLC | 5,483,369 2.480% | 5,483,369 (New Position) | Filing History |